Both DOC and VCR drugs are a substrate of the ABCB1 transporter/p-glycoprotein (P-gp), and thus a high level of P-gp expression in cancer cells is predicted to develop drug resistance to DOC and VCR [3,4]. This evidence concerns the gene PGP and cancer.